| abstract |
A novel transdermal pharmaceutical polymer matrix dosage unit is provided which comprises a backing layer, an adjoining layer of a solid polymer matrix in which the pharmaceutical is microdispersed and a final biologically acceptable adhesive polymer layer which has dispersed therein a skin permeation enhancer. |